Spero Therapeutics, Inc. - COM (SPRO)

Historical Portfolio Holders from Q4 2017 to Q1 2024

All holders as of March 31, 2024
Q1 2024
Type / Class
Equity / COM
Shares, excl. options Q1 2024
13.7 M
Holdings value Q1 2024
$23.6 M
Value change Q1 2024
-$8.23 K
Grand Portfolio weight change Q1 2024
0%
Number of holders
48
Number of buys Q1 2024
19
Number of sells Q1 2024
-16
Average buys Q1 2024 %
+0%
Average sells Q1 2024 %
0%
CUSIP
84833T103
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q1 13.7 M $23.6 M -$8.23 K $1.72 49
2023 Q4 13.3 M $19.6 M +$231 K $1.47 42
2023 Q3 14.2 M $17.2 M -$231 K $1.21 50
2023 Q2 14.4 M $20.8 M +$16.8 K $1.45 54
2023 Q1 10.9 M $15.7 M -$483 K $1.45 43
2022 Q4 11.2 M $19.4 M -$13.8 M $1.73 55
2022 Q3 17.5 M $35 M -$3.19 M $2.00 55
2022 Q2 20.7 M $15.3 M -$13.8 M $0.74 56
2022 Q1 20.2 M $176 M +$3.32 M $8.70 95
2021 Q4 19.8 M $316 M +$2.06 M $16.01 79
2021 Q3 18.4 M $338 M +$16.4 M $18.41 86
2021 Q2 16.1 M $225 M -$17.5 M $13.96 81
2021 Q1 17.4 M $256 M +$11.6 M $14.72 85
2020 Q4 18.6 M $360 M +$25.8 M $19.39 84
2020 Q3 16.7 M $187 M +$55.2 M $11.16 75
2020 Q2 11.8 M $159 M +$6.84 M $13.53 74
2020 Q1 10.9 M $87.8 M +$4.24 M $8.08 55
2019 Q4 10.8 M $104 M +$4.17 M $9.61 59
2019 Q3 10.4 M $110 M -$2.84 M $10.60 55
2019 Q2 10.6 M $122 M +$15.8 M $11.51 58
2019 Q1 9.26 M $119 M +$3.65 M $12.81 52
2018 Q4 9.1 M $56 M -$16.9 M $6.15 47
2018 Q3 10.7 M $113 M +$24.5 M $10.51 49
2018 Q2 8.12 M $119 M +$21.7 K $14.67 39
2018 Q1 7.69 M $110 M -$787 K $14.25 31
2017 Q4 7.76 M $91.1 M +$91 M $11.75 34